Challenges and Strategies in Advancing miRNA-based Cancer Therapeutics.

B W M Nor WMFS, Yong CL, Mahmood S, Said NABM.

DOI: 10.2174/0113892010454262260713171301
Published: 2026-07-22
Container: Curr Pharm Biotechnol
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2174/0113892010454262260713171301,
  title = {Challenges and Strategies in Advancing miRNA-based Cancer Therapeutics.},
  author = {B W M Nor WMFS and  Yong CL and  Mahmood S and  Said NABM.},
  year = {2026},
  journal = {Curr Pharm Biotechnol},
  doi = {10.2174/0113892010454262260713171301},
  url = {https://doi.org/10.2174/0113892010454262260713171301}
}

RIS

TY  - JOUR
TI  - Challenges and Strategies in Advancing miRNA-based Cancer Therapeutics.
AU  - B W M Nor WMFS
AU  -  Yong CL
AU  -  Mahmood S
AU  -  Said NABM.
PY  - 2026
JO  - Curr Pharm Biotechnol
DO  - 10.2174/0113892010454262260713171301
UR  - https://doi.org/10.2174/0113892010454262260713171301
ER  -

APA

WMFS, B. W. M. N., CL, Y., S, M., & NABM., S. (2026). Challenges and Strategies in Advancing miRNA-based Cancer Therapeutics.. Curr Pharm Biotechnol. https://doi.org/10.2174/0113892010454262260713171301

Source records

europe-pmc · retrieved 2026-09-27T05:07:19.094Z